Diagnostic Ultrasound Devices Market by Device Type (Handheld Devices, Portable Systems, Standalone Systems), Technology (2D Ultrasound, 3D and 4D Ultrasound, Contrast Enhanced Ultrasound), Transducer Type, Frequency, Application, End User - Global Foreca
Description
The Diagnostic Ultrasound Devices Market was valued at USD 10.29 billion in 2025 and is projected to grow to USD 10.82 billion in 2026, with a CAGR of 5.35%, reaching USD 14.82 billion by 2032.
Understanding how technological progress and evolving care delivery models are reshaping diagnostic ultrasound utilization and procurement priorities in clinical practice
The diagnostic ultrasound landscape sits at the intersection of medical imaging innovation and front-line clinical demand. As care models evolve toward decentralized diagnostics and value-based outcomes, ultrasound technology has shifted from a modality confined to radiology suites to a versatile tool deployed across ambulatory clinics, emergency departments, and community health settings. Recent advances in probe miniaturization, image processing, and user interfaces have expanded the contexts in which ultrasound can deliver rapid, high-quality insights, reducing time to diagnosis and enabling point-of-care decision-making.
Concurrently, software-driven capabilities have begun to redefine the modalities of scanning, with computational imaging and automated measurements turning complex examinations into workflow-friendly protocols. This transition is underpinned by a stronger emphasis on clinician ergonomics and interoperable data flows that integrate ultrasound results into electronic health records and telemedicine platforms. As a result, stakeholders across clinical operations, procurement, and product development are recalibrating priorities to balance device performance with usability, connectivity, and total cost of ownership, setting the stage for strategic investments and competitive repositioning across the ecosystem.
How converging hardware miniaturization, AI-driven imaging, and telemedicine integration are redefining competitive dynamics and clinical adoption patterns in ultrasound
The past several years have witnessed transformative shifts across hardware, software, and delivery frameworks that together redefine the competitive landscape for diagnostic ultrasound. Hardware innovation has reduced device size and weight, enabling handheld and portable form factors that are critical for point-of-care applications. At the same time, software innovation has elevated image quality through AI-assisted image enhancement, automated annotation, and pattern recognition tools that improve reproducibility and reduce operator dependency.
Service delivery models have also pivoted, as telemedicine platforms incorporate real-time image streaming and remote guidance to extend specialist expertise into underserved settings. This has been accompanied by new commercial approaches, including device-as-a-service and subscription models, which alter procurement cycles and enable faster technology refresh. Moreover, regulatory pathways have adapted to accommodate software updates and AI-driven features, prompting manufacturers to design lifecycle management strategies that support continuous clinical validation. Together, these shifts compel legacy manufacturers and newcomers alike to align product roadmaps with interoperability, cybersecurity, and clinical workflow integration to sustain adoption across diverse care settings.
Assessing how tariff-driven trade policy changes in 2025 are reshaping supply chains, procurement behavior, and manufacturing localization choices for ultrasound suppliers
Policy and trade developments enacted with effect in 2025 introduced additional variables that influence supply chains, procurement strategies, and manufacturing footprints for diagnostic ultrasound devices intended for the United States market. The cumulative impact of tariffs and related trade measures has incentivized manufacturers to reassess supplier diversity and regional sourcing to mitigate input-cost volatility. As a result, there is an observable acceleration in dual-sourcing strategies and nearshoring conversations aimed at protecting margins and maintaining lead times for key components such as probes, electronic boards, and imaging chips.
In parallel, procurement teams in healthcare systems are recalibrating total cost assessments to account for potential tariff-driven price adjustments, leading to longer evaluation cycles and increased interest in service-based acquisition models that can smooth capital expenditure. These dynamics have also sharpened negotiation leverage for large integrated health systems and group purchasing organizations, which seek bundled service agreements and extended warranties. Ultimately, the policy environment has amplified the importance of supply chain transparency and contractual flexibility, motivating both OEMs and suppliers to embed tariff-risk mitigation into product sourcing and commercial strategies.
Integrating device type, imaging modalities, clinical applications, probe technology, end-user context, and frequency selection to reveal practical adoption pathways and product opportunities
A nuanced understanding of device demand emerges when segmentation parameters are viewed as interdependent drivers rather than isolated categories. Device type distinctions, from compact handheld devices to more expansive cart-based and tower standalone systems, dictate use-case suitability across point-of-care and institutional settings; portable systems further split into compact and laptop-based platforms that balance mobility with image-processing capability. Technology layers such as two-dimensional imaging, volumetric 3D and 4D modalities, contrast-enhanced techniques, and Doppler functionality determine clinical applicability, influencing how devices are configured for specialties that require detailed anatomical visualization or hemodynamic assessment.
Application areas provide a practical lens for adoption patterns: cardiac imaging protocols benefit from advanced Doppler and phased-array probe configurations, musculoskeletal practice favors high-frequency linear arrays for near-surface resolution, and obstetrics and gynecology require volumetric and Doppler capabilities for comprehensive fetal and uterine assessment. Transducer diversity-convex, endocavity, linear, mechanical, and phased arrays-further tailors the diagnostic profile to particular anatomical targets and workflows. End-user environments such as ambulatory care centers, clinics, diagnostic centers, and hospitals impose distinct throughput, sterilization, and space constraints that influence device choice, while frequency selection between high and low bands has material implications for penetration depth and spatial resolution. Synthesizing these segmentation layers reveals where product innovation and commercial focus can yield differentiated clinical value and where modular architectures can extend device utility across multiple user groups.
Regional demand drivers and infrastructure differences across major global markets that dictate product configuration, distribution, and clinical adoption strategies
Geographic dynamics influence adoption curves, supply chain design, and competitive positioning in distinct ways across major regions. In the Americas, advanced hospital systems and expanding point-of-care networks favor rapid uptake of handheld and portable systems, with strong demand for integrated tele-ultrasound and AI-assisted workflow tools that support distributed care. In Europe, Middle East & Africa, heterogeneity in healthcare infrastructure drives a bifurcated profile where well-resourced centers adopt high-end volumetric and Doppler-capable systems while many community providers prioritize compact and cost-effective options that support broader screening and primary care workflows.
The Asia-Pacific region exhibits robust investment in diagnostic capacity, along with localized manufacturing growth and increasing adoption of both portable and advanced standalone systems. Across these geographies, regulatory frameworks, reimbursement structures, and workforce training resources create differentiated priorities: some markets emphasize point-of-care expansion and rapid deployment, while others concentrate on tertiary clinical capabilities and integrated imaging networks. Consequently, regional strategies must balance product configurations, training programs, and channel partnerships to match local clinical needs and procurement norms.
How incumbents and agile challengers are redefining competitive advantage through software ecosystems, service offerings, and strategic channel partnerships
Competitive positioning in diagnostic ultrasound is being influenced by a dual imperative: sustain core imaging performance while accelerating software and service innovation. Established OEMs continue to leverage brand trust, distribution scale, and clinical validation to support enterprise-scale deployments and high-end imaging systems. At the same time, agile challengers and specialized technology firms are making targeted inroads by offering handheld devices, streamlined user interfaces, and AI-enabled features that reduce operator training burden and expand use cases in primary care and emergency medicine.
Strategic partnerships and ecosystem plays are increasingly common, with manufacturers collaborating with software vendors, cloud platform providers, and clinical networks to deliver end-to-end solutions. This integration enhances product stickiness through data continuity and advanced analytics capabilities. Moreover, companies that offer comprehensive training, remote support, and managed service contracts are seeing stronger long-term engagement from institutional customers. Moving forward, the most successful organizations will be those that balance hardware excellence with modular software ecosystems, robust clinician support, and flexible commercial models that align with evolving procurement preferences.
Actionable priorities for leaders to align product modularity, AI-enabled workflows, supply diversification, and commercial models for sustained adoption and resilience
Industry leaders should prioritize a set of pragmatic actions to capture clinical momentum while insulating operations from policy and supply-chain volatility. First, invest in modular platform architectures that allow rapid configuration between handheld, portable, and standalone systems so that one core platform can address multiple end-user needs and application domains. Second, accelerate integration of AI-driven image enhancement and guided protocols to lower operator dependence, shorten training curves, and improve diagnostic consistency across care settings. Third, diversify supply chains and pursue nearshoring or regional manufacturing partnerships to reduce exposure to tariff fluctuations and to ensure rapid replenishment of critical components.
In addition, commercial teams should pilot subscription and device-as-a-service arrangements to offer procurement flexibility and predictable revenue, while clinical education programs should be scaled through blended learning approaches that combine remote simulation, on-device guidance, and targeted onsite training. Finally, establish clear data governance and interoperability roadmaps that prioritize standards-based interfaces and cybersecurity measures, thereby enabling safer tele-ultrasound deployments and seamless integration with health information systems.
Transparent research methodology combining stakeholder interviews, technical literature review, and triangulated analysis to validate strategic conclusions and implications
This research synthesizes insights derived from a structured combination of primary and secondary evidence, triangulated to strengthen validity and applicability for strategic use. Primary inputs include interviews with clinical stakeholders, biomedical engineers, procurement specialists, and industry executives to capture first-hand perspectives on usability, operational constraints, and procurement drivers. Secondary inputs draw on peer-reviewed literature, regulatory guidance, technical white papers, and company disclosures to establish a foundation of technological and clinical context.
Analytical approaches included qualitative thematic analysis to identify emerging patterns in workflow integration and clinician needs, as well as cross-sectional mapping of product features against clinical applications to identify capability gaps. Data validation occurred through iterative stakeholder review and scenario testing to ensure conclusions withstand operational variability. The methodology emphasizes transparency in assumptions, conservative interpretation of qualitative signals, and clear linkage between evidence sources and analytical conclusions to support confident decision-making.
Concluding synthesis on how integrated product, commercial, and operational strategies will determine success amid technological progress and supply-chain pressures
Diagnostic ultrasound stands at a pivotal moment where technological advances, shifting care models, and policy dynamics jointly shape near-term strategic choices. The modality’s trajectory is defined by an expanding role beyond traditional imaging suites into point-of-care applications facilitated by handheld and portable platforms, alongside continuous improvements in image fidelity through AI and advanced modalities. At the same time, trade and supply-chain pressures underscore the need for resilient sourcing and commercial flexibility, reinforcing that product excellence alone will not guarantee success without parallel investments in services, training, and local market alignment.
Looking ahead, organizations that marry modular hardware strategies with software ecosystems, prioritize clinician-centered design, and implement robust supply-risk mitigation will be best positioned to capture diverse clinical opportunities. In sum, a holistic approach that integrates product, commercial, and operational tactics will enable stakeholders to deliver meaningful clinical value while navigating a dynamic regulatory and economic environment.
Note: PDF & Excel + Online Access - 1 Year
Understanding how technological progress and evolving care delivery models are reshaping diagnostic ultrasound utilization and procurement priorities in clinical practice
The diagnostic ultrasound landscape sits at the intersection of medical imaging innovation and front-line clinical demand. As care models evolve toward decentralized diagnostics and value-based outcomes, ultrasound technology has shifted from a modality confined to radiology suites to a versatile tool deployed across ambulatory clinics, emergency departments, and community health settings. Recent advances in probe miniaturization, image processing, and user interfaces have expanded the contexts in which ultrasound can deliver rapid, high-quality insights, reducing time to diagnosis and enabling point-of-care decision-making.
Concurrently, software-driven capabilities have begun to redefine the modalities of scanning, with computational imaging and automated measurements turning complex examinations into workflow-friendly protocols. This transition is underpinned by a stronger emphasis on clinician ergonomics and interoperable data flows that integrate ultrasound results into electronic health records and telemedicine platforms. As a result, stakeholders across clinical operations, procurement, and product development are recalibrating priorities to balance device performance with usability, connectivity, and total cost of ownership, setting the stage for strategic investments and competitive repositioning across the ecosystem.
How converging hardware miniaturization, AI-driven imaging, and telemedicine integration are redefining competitive dynamics and clinical adoption patterns in ultrasound
The past several years have witnessed transformative shifts across hardware, software, and delivery frameworks that together redefine the competitive landscape for diagnostic ultrasound. Hardware innovation has reduced device size and weight, enabling handheld and portable form factors that are critical for point-of-care applications. At the same time, software innovation has elevated image quality through AI-assisted image enhancement, automated annotation, and pattern recognition tools that improve reproducibility and reduce operator dependency.
Service delivery models have also pivoted, as telemedicine platforms incorporate real-time image streaming and remote guidance to extend specialist expertise into underserved settings. This has been accompanied by new commercial approaches, including device-as-a-service and subscription models, which alter procurement cycles and enable faster technology refresh. Moreover, regulatory pathways have adapted to accommodate software updates and AI-driven features, prompting manufacturers to design lifecycle management strategies that support continuous clinical validation. Together, these shifts compel legacy manufacturers and newcomers alike to align product roadmaps with interoperability, cybersecurity, and clinical workflow integration to sustain adoption across diverse care settings.
Assessing how tariff-driven trade policy changes in 2025 are reshaping supply chains, procurement behavior, and manufacturing localization choices for ultrasound suppliers
Policy and trade developments enacted with effect in 2025 introduced additional variables that influence supply chains, procurement strategies, and manufacturing footprints for diagnostic ultrasound devices intended for the United States market. The cumulative impact of tariffs and related trade measures has incentivized manufacturers to reassess supplier diversity and regional sourcing to mitigate input-cost volatility. As a result, there is an observable acceleration in dual-sourcing strategies and nearshoring conversations aimed at protecting margins and maintaining lead times for key components such as probes, electronic boards, and imaging chips.
In parallel, procurement teams in healthcare systems are recalibrating total cost assessments to account for potential tariff-driven price adjustments, leading to longer evaluation cycles and increased interest in service-based acquisition models that can smooth capital expenditure. These dynamics have also sharpened negotiation leverage for large integrated health systems and group purchasing organizations, which seek bundled service agreements and extended warranties. Ultimately, the policy environment has amplified the importance of supply chain transparency and contractual flexibility, motivating both OEMs and suppliers to embed tariff-risk mitigation into product sourcing and commercial strategies.
Integrating device type, imaging modalities, clinical applications, probe technology, end-user context, and frequency selection to reveal practical adoption pathways and product opportunities
A nuanced understanding of device demand emerges when segmentation parameters are viewed as interdependent drivers rather than isolated categories. Device type distinctions, from compact handheld devices to more expansive cart-based and tower standalone systems, dictate use-case suitability across point-of-care and institutional settings; portable systems further split into compact and laptop-based platforms that balance mobility with image-processing capability. Technology layers such as two-dimensional imaging, volumetric 3D and 4D modalities, contrast-enhanced techniques, and Doppler functionality determine clinical applicability, influencing how devices are configured for specialties that require detailed anatomical visualization or hemodynamic assessment.
Application areas provide a practical lens for adoption patterns: cardiac imaging protocols benefit from advanced Doppler and phased-array probe configurations, musculoskeletal practice favors high-frequency linear arrays for near-surface resolution, and obstetrics and gynecology require volumetric and Doppler capabilities for comprehensive fetal and uterine assessment. Transducer diversity-convex, endocavity, linear, mechanical, and phased arrays-further tailors the diagnostic profile to particular anatomical targets and workflows. End-user environments such as ambulatory care centers, clinics, diagnostic centers, and hospitals impose distinct throughput, sterilization, and space constraints that influence device choice, while frequency selection between high and low bands has material implications for penetration depth and spatial resolution. Synthesizing these segmentation layers reveals where product innovation and commercial focus can yield differentiated clinical value and where modular architectures can extend device utility across multiple user groups.
Regional demand drivers and infrastructure differences across major global markets that dictate product configuration, distribution, and clinical adoption strategies
Geographic dynamics influence adoption curves, supply chain design, and competitive positioning in distinct ways across major regions. In the Americas, advanced hospital systems and expanding point-of-care networks favor rapid uptake of handheld and portable systems, with strong demand for integrated tele-ultrasound and AI-assisted workflow tools that support distributed care. In Europe, Middle East & Africa, heterogeneity in healthcare infrastructure drives a bifurcated profile where well-resourced centers adopt high-end volumetric and Doppler-capable systems while many community providers prioritize compact and cost-effective options that support broader screening and primary care workflows.
The Asia-Pacific region exhibits robust investment in diagnostic capacity, along with localized manufacturing growth and increasing adoption of both portable and advanced standalone systems. Across these geographies, regulatory frameworks, reimbursement structures, and workforce training resources create differentiated priorities: some markets emphasize point-of-care expansion and rapid deployment, while others concentrate on tertiary clinical capabilities and integrated imaging networks. Consequently, regional strategies must balance product configurations, training programs, and channel partnerships to match local clinical needs and procurement norms.
How incumbents and agile challengers are redefining competitive advantage through software ecosystems, service offerings, and strategic channel partnerships
Competitive positioning in diagnostic ultrasound is being influenced by a dual imperative: sustain core imaging performance while accelerating software and service innovation. Established OEMs continue to leverage brand trust, distribution scale, and clinical validation to support enterprise-scale deployments and high-end imaging systems. At the same time, agile challengers and specialized technology firms are making targeted inroads by offering handheld devices, streamlined user interfaces, and AI-enabled features that reduce operator training burden and expand use cases in primary care and emergency medicine.
Strategic partnerships and ecosystem plays are increasingly common, with manufacturers collaborating with software vendors, cloud platform providers, and clinical networks to deliver end-to-end solutions. This integration enhances product stickiness through data continuity and advanced analytics capabilities. Moreover, companies that offer comprehensive training, remote support, and managed service contracts are seeing stronger long-term engagement from institutional customers. Moving forward, the most successful organizations will be those that balance hardware excellence with modular software ecosystems, robust clinician support, and flexible commercial models that align with evolving procurement preferences.
Actionable priorities for leaders to align product modularity, AI-enabled workflows, supply diversification, and commercial models for sustained adoption and resilience
Industry leaders should prioritize a set of pragmatic actions to capture clinical momentum while insulating operations from policy and supply-chain volatility. First, invest in modular platform architectures that allow rapid configuration between handheld, portable, and standalone systems so that one core platform can address multiple end-user needs and application domains. Second, accelerate integration of AI-driven image enhancement and guided protocols to lower operator dependence, shorten training curves, and improve diagnostic consistency across care settings. Third, diversify supply chains and pursue nearshoring or regional manufacturing partnerships to reduce exposure to tariff fluctuations and to ensure rapid replenishment of critical components.
In addition, commercial teams should pilot subscription and device-as-a-service arrangements to offer procurement flexibility and predictable revenue, while clinical education programs should be scaled through blended learning approaches that combine remote simulation, on-device guidance, and targeted onsite training. Finally, establish clear data governance and interoperability roadmaps that prioritize standards-based interfaces and cybersecurity measures, thereby enabling safer tele-ultrasound deployments and seamless integration with health information systems.
Transparent research methodology combining stakeholder interviews, technical literature review, and triangulated analysis to validate strategic conclusions and implications
This research synthesizes insights derived from a structured combination of primary and secondary evidence, triangulated to strengthen validity and applicability for strategic use. Primary inputs include interviews with clinical stakeholders, biomedical engineers, procurement specialists, and industry executives to capture first-hand perspectives on usability, operational constraints, and procurement drivers. Secondary inputs draw on peer-reviewed literature, regulatory guidance, technical white papers, and company disclosures to establish a foundation of technological and clinical context.
Analytical approaches included qualitative thematic analysis to identify emerging patterns in workflow integration and clinician needs, as well as cross-sectional mapping of product features against clinical applications to identify capability gaps. Data validation occurred through iterative stakeholder review and scenario testing to ensure conclusions withstand operational variability. The methodology emphasizes transparency in assumptions, conservative interpretation of qualitative signals, and clear linkage between evidence sources and analytical conclusions to support confident decision-making.
Concluding synthesis on how integrated product, commercial, and operational strategies will determine success amid technological progress and supply-chain pressures
Diagnostic ultrasound stands at a pivotal moment where technological advances, shifting care models, and policy dynamics jointly shape near-term strategic choices. The modality’s trajectory is defined by an expanding role beyond traditional imaging suites into point-of-care applications facilitated by handheld and portable platforms, alongside continuous improvements in image fidelity through AI and advanced modalities. At the same time, trade and supply-chain pressures underscore the need for resilient sourcing and commercial flexibility, reinforcing that product excellence alone will not guarantee success without parallel investments in services, training, and local market alignment.
Looking ahead, organizations that marry modular hardware strategies with software ecosystems, prioritize clinician-centered design, and implement robust supply-risk mitigation will be best positioned to capture diverse clinical opportunities. In sum, a holistic approach that integrates product, commercial, and operational tactics will enable stakeholders to deliver meaningful clinical value while navigating a dynamic regulatory and economic environment.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
183 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Definition
- 1.3. Market Segmentation & Coverage
- 1.4. Years Considered for the Study
- 1.5. Currency Considered for the Study
- 1.6. Language Considered for the Study
- 1.7. Key Stakeholders
- 2. Research Methodology
- 2.1. Introduction
- 2.2. Research Design
- 2.2.1. Primary Research
- 2.2.2. Secondary Research
- 2.3. Research Framework
- 2.3.1. Qualitative Analysis
- 2.3.2. Quantitative Analysis
- 2.4. Market Size Estimation
- 2.4.1. Top-Down Approach
- 2.4.2. Bottom-Up Approach
- 2.5. Data Triangulation
- 2.6. Research Outcomes
- 2.7. Research Assumptions
- 2.8. Research Limitations
- 3. Executive Summary
- 3.1. Introduction
- 3.2. CXO Perspective
- 3.3. Market Size & Growth Trends
- 3.4. Market Share Analysis, 2025
- 3.5. FPNV Positioning Matrix, 2025
- 3.6. New Revenue Opportunities
- 3.7. Next-Generation Business Models
- 3.8. Industry Roadmap
- 4. Market Overview
- 4.1. Introduction
- 4.2. Industry Ecosystem & Value Chain Analysis
- 4.2.1. Supply-Side Analysis
- 4.2.2. Demand-Side Analysis
- 4.2.3. Stakeholder Analysis
- 4.3. Porter’s Five Forces Analysis
- 4.4. PESTLE Analysis
- 4.5. Market Outlook
- 4.5.1. Near-Term Market Outlook (0–2 Years)
- 4.5.2. Medium-Term Market Outlook (3–5 Years)
- 4.5.3. Long-Term Market Outlook (5–10 Years)
- 4.6. Go-to-Market Strategy
- 5. Market Insights
- 5.1. Consumer Insights & End-User Perspective
- 5.2. Consumer Experience Benchmarking
- 5.3. Opportunity Mapping
- 5.4. Distribution Channel Analysis
- 5.5. Pricing Trend Analysis
- 5.6. Regulatory Compliance & Standards Framework
- 5.7. ESG & Sustainability Analysis
- 5.8. Disruption & Risk Scenarios
- 5.9. Return on Investment & Cost-Benefit Analysis
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Diagnostic Ultrasound Devices Market, by Device Type
- 8.1. Handheld Devices
- 8.2. Portable Systems
- 8.2.1. Compact Systems
- 8.2.2. Laptop Systems
- 8.3. Standalone Systems
- 8.3.1. Cart Based Systems
- 8.3.2. Tower Systems
- 9. Diagnostic Ultrasound Devices Market, by Technology
- 9.1. 2D Ultrasound
- 9.2. 3D and 4D Ultrasound
- 9.3. Contrast Enhanced Ultrasound
- 9.4. Doppler Ultrasound
- 10. Diagnostic Ultrasound Devices Market, by Transducer Type
- 10.1. Convex Array
- 10.2. Endocavity Transducer
- 10.3. Linear Array
- 10.4. Mechanical Transducer
- 10.5. Phased Array
- 11. Diagnostic Ultrasound Devices Market, by Frequency
- 11.1. High Frequency
- 11.2. Low Frequency
- 12. Diagnostic Ultrasound Devices Market, by Application
- 12.1. Cardiology
- 12.2. Musculoskeletal
- 12.3. Obstetrics and Gynecology
- 12.4. Radiology
- 12.5. Urology
- 12.6. Vascular
- 13. Diagnostic Ultrasound Devices Market, by End User
- 13.1. Ambulatory Care
- 13.2. Clinic
- 13.3. Diagnostic Center
- 13.4. Hospital
- 14. Diagnostic Ultrasound Devices Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Diagnostic Ultrasound Devices Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Diagnostic Ultrasound Devices Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. United States Diagnostic Ultrasound Devices Market
- 18. China Diagnostic Ultrasound Devices Market
- 19. Competitive Landscape
- 19.1. Market Concentration Analysis, 2025
- 19.1.1. Concentration Ratio (CR)
- 19.1.2. Herfindahl Hirschman Index (HHI)
- 19.2. Recent Developments & Impact Analysis, 2025
- 19.3. Product Portfolio Analysis, 2025
- 19.4. Benchmarking Analysis, 2025
- 19.5. Canon Medical Systems Corporation
- 19.6. Esaote S.p.A.
- 19.7. FUJIFILM Holdings Corporation
- 19.8. GE Healthcare
- 19.9. Hitachi, Ltd.
- 19.10. Koninklijke Philips N.V.
- 19.11. Neusoft Medical Systems Co., Ltd.
- 19.12. Samsung Electronics Co., Ltd.
- 19.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 19.14. Siemens Healthineers AG
- 19.15. SonoScape Medical Corporation
- 19.16. United Imaging Healthcare
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
